The Influence of Mediators in the Growth of Malignant Tumors
DOI:
https://doi.org/10.5644/Radovi.159Abstract
5 different pharmacologic groups capable of decreasing or increasing transmitter substances an organism (noradrenalin, adrenalin, serotonin, histamine, acetylcholine) were examined, besides amino acids glycine and GABA were also examined. These substances were administrated to mice with carcinoma, sarcoma or leukaemia it was shown that there is probably correlation between the quantity of adrenaline and growth of tumour. It was also shown that glycine inhibits growth of some malignant tumours.
References
Ablad B., Brogard M., Ek. L.: Pharmacological properties of H 56/28. A beta-adrenergic receptor antagonist. Acta Pharmacol. et Toxicol. 25 Suppl. 2, (1967).
Biesele J., Berger R., Clarke M.: Cancer Research 12, 399 (1952).
Cit. prema: Stern P., Japelj M., Pavletić B. »Značenje zamjene željeza i kobalta u nekim spojevima na njihova antimaligna djelovanja. Radovi XXXVII, Odjeljenje medicinskih nauka Akademije nauka i umjetnosti BiH, knjiga 14, Sarajevo 1969.
Bovet D., Bovet-Nitti F.: Medicaments du systeme nerveux vegetatif. S. Karger, Basel 1948.
Biichner F.; Iz: Handbuch der allgemeinen Pathologie, VI-Bd, 3. Teil "Geschwiilste" Springer Verlag, Berlin, Gottingen, Heidelberg, 1956.
Chiou C. Y., Ra ma Sastry B. V.: Vascular rcsponses of halogenoacetylcholines in the dog. Arch. int. Pharmacodyn. 181, 94—100 (1969).
Crout J. R.: Inhibition of Catechol-O-Methyl transferase by Pyrogallol in the rat. Biochem. Pharmacol. 6, 47—50 (1961).
Devoino L. V., Ilyutchenok R. Yu.: Influence of some drugs on the immune response II. Effects of serotonin, 5-hydroxytryptophan, reserpine and iproniazid on delayed hypersensitivity. Eiirop. J. Pharmacol. 4, 449—456 (1968).
Devoino L. V., Koro vina L. S., Ilyutchenok R. Y u.: Influence of some drugs on the immune response. I. The effect of 5-hydroxytryptophan, Iproniazid and reserpine on primary and sccondary immune responses. Europ. J. Pharmacol. 4, 441—448 (1968).
Fischer H.: Vergleichende Pharmakologie von Ubertragersubstanzen in tiersystematischer Darstellung. Handbuch der experimentellen Pharmakologie Bd. XXVI, Springer-Verlag, Berlin, Heidelberg, New York, 1971.
Frontini E., Giani G., Nikolin A., Olivani P., Histamine in regenerating liver. Archiv fiir Pharmakologie 269, 418—419 (1971).
Garattini S., Valzelli L.: Serotonin, Elsevier, Amsterdam, London, New York, 1965.
Giolli A., Maiinaioni P. F.: Adrenergic dnfluences on histamine release. Biochemica applicata XIV, suppl. 1, 267 (1968).
Goldstein M.: Dopamine — hydroxylase: A copper enzyme. In: "The biochemistry of copper" ed. Peisach, J., Aisen, P., Blumberg, W. E., Academic Press, New York, 1966, 4431—454.
Goodman L. S., Gilman A.: "The pharmacological basis of therapeutics" IV. Edit. The Macmillan Comp., New York, 1970.
Graham L. T. Jr., Shanik R. P., Werman R., Aprison M. H.: Distribution of some synaptic transmitter suspects in cat spinal cord: glutamic acid, aspartic acid, -aminobutyric acid, glycine and glutamine. J. Neurochemistry, 14, 465 (1967).
Haartmann, Ulla von, Kahlson G., Steinhardt, Claudia: Histamine formation in germinating seeds. Life Sciences 5, 1—9 (1965).
Jaques R., Lewis G. P.: Guanethidine as a histamine liberator. Pharmacology 4, 316—320 (1970).
Jasmin G.: Effect of a histamine releaser (4'8/80) upon development of Walker tumor. Proc. Soc. cxper. Biol. Med. 96, 570—572 (1957).
Johnston M., Kahlson G.: Experiments on the inhibition of histamine formation in the rat. Br. J. Pharmac. Chemother. 30, 274 (1967).
Kenneth B. K., Weissman A.: Marked depletion of brain serotonin by p-chlorophenylalanine. Fed. Proc. 25, 452 (1966).
Košak R., Stern P.: Prilog utjecaju histamina na zarašćivanje rana. Acta pharmaceutica lugoslavica 8, 47—50 (1958).
Law L. W., Dunn T. B., Miller P. J.: J. Nat. Cancer Inst. 10, 179 (1949).
Cit. prema: Stern P., Japelj M., Pavletić B. »Značenje zamjene željeza i kobalta u nekim spojevima na njihova antimaligna djelovanja. Radovi XXXVII, Odjeljenje med. nauka Akademije nauka i umjetnosti BiH, knjiga 14, Sarajevo 1969.
Loewenthal H., Jahn G.: Ztschr. Krebsforsch. 37, 439 (1932). Cit. prema Stern P., Japelj M., Pavletić B. »Značenje zamjene željeza i kobalta u nekim spojevima na njihova antimaligna djelovanja. Radovi XXXVII, Odjeljenje medicinskih nauka Akademije nauka i umjetnosti BiH, knjiga 14, Sarajevo 1969.
Neishw, J. P.: Phenylacetic acid as a potential therapeutic agent for the treatment of human cancer. Experientia 27, 860 (1971).
Parratt J. R., West G. B.: 5-Hydroxytryptamine and the anaphylactoid reaction in the rat. J. Physiol. (Lond.) 139, 27 (1957).
Popov N., Matthies H.: Some effects of monoamine oxidase inhibitors on the metabolism of -aminobutyric acid in rat brain. J. Neurochemistry 16, 899 (1969).
Scheinberg J. H., Sternlieb L.: Penicillamine as the basis of therapy in Wilson’s disease, in: »Metal-bindung in medicine« eds. Seven, M. J. Lippincct, H. B. Co, Philadelphia (1960).
Schmahl D.: privatno saopštenje.
Stern P.: "Symposium on Substance P." Naučno društvo NRBiH. Posebna izdanja, vol. I., knjiga 1, Odjeljenje medicinskih nauka, Sarajevo 1961.
Taylor R. J., Stubbs C. S., J r., Ellenbogen L.: Tyrosine hydroxylase inhibition in vitro and in vivo by chelating agents. Biochemical. Pharmacol. 18, 587—594 (1969).
Tomić S., Vukčević S.: O imunološkom aspektu raka. Medicinski vjesnik, br. 1—2, 25—41, 1968.
Tripod J.: Tierexperimcnteller Nachweis der Affinitat von Desferal fur Eisen. Schweiz. med. Wschrft. 93, 969—973 (1963).
Vane J. R., Wolstenholme G. E. W., O'Connor M.: "Adrenergic Mechanisms", J. a. A. Churchill, Ltd, London, 1960.
Zeller E. A.: The fate of histamine in the body, with particular reference to the enzymology of histamine oxidation. In: "Histamine" edit. Wolstenholme, G. E. W., O’Connor, C. M., J. and A. Churchill, Ltd, London. 1956, p. 339.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pavel Štern
This work is licensed under a Creative Commons Attribution 4.0 International License.
